Our Mission

To improve patient outcomes by developing first-in-class small molecule inhibitors of the Myc oncoprotein as safe and effective treatments for cancer.

Who we are

Our team of experienced scientific leaders and drug discovery professionals.

Read more

What we do

The science of Myc inhibition as a treatment for cancer.

Read more

Our Partners

The people helping us to lead the way.

Read more


Company announcements and news.

Read more


MycRx is a privately-held biotech company developing small molecule inhibitors of the Myc oncoprotein, located in Melbourne, Australia.

Read more